Clinical and Regulatory committee

Clinical and Regulatory committee

The Clinical and Regulatory Committee is appointed within the Board and deals with issues regarding the Company’s clinical development plan and clinical trials for arfolitixorin as well as regulatory issues with authorities.

The committee consists of the chairman Ulf Jungnelius and Alain Herrera.

The committee has the following main areas of responsibility:

  • To support the company’s management in supervising ongoing clinical studies as well as.
  • To generate proposals for new clinical studies and research that support the company’s development of arfolitixorin.
  • To be involved in evaluating documentation in interactions with regulatory authorities.
  • To support the company’s management in evaluating patient data.